Home > News > Gene technology moves forward at Mirus Bio
July 30th, 2007
Gene technology moves forward at Mirus Bio
Abstract:
Mirus later developed two methods for delivery intravenously via the veins, similar to administering an IV. Such a procedure can be done in 10 to 15 minutes, and is similar to giving blood, except that the material goes into the body rather than being withdrawn.
The first, "hydrodynamic intravascular injection," involves pressurized delivery of nucleic acids through the bloodstream to surrounding cells and tissues. This enables regional delivery to a limb or other targeted area of the body.
The second delivery platform involves nanoparticle formulations that are delivered via a standard IV injection -- no pressure is involved -- and can be targeted to specific tissues and cells without being limited to the area of injection.
Source:
madison.com
Bookmark:
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||